Inspire Medical Systems
Stock Forecast, Prediction & Price Target
Inspire Medical Systems (INSP) stock Price Target by analysts
$250.67
Potential upside: 178.33%
Inspire Medical Systems price prediction
What is Inspire Medical Systems stock analysts` prediction?
Inspire Medical Systems stock forecast: Based on 2 Wall Street analysts` predicted price targets for Inspire Medical Systems in the last 3 months, the avarage price target is $250.67, with a high forecast of $NaN. The average price target represents a 178.33% change from the last price of $90.06.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Inspire Medical Systems stock Price Target by analysts
Full breakdown of analysts given Inspire Medical Systems price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Adam Maeder Piper Sandler | 33.33% 1/3 | 10 months ago | $260 188.69% upside | $199 | StreetInsider | Previous targets (2) |
David Rescott Robert W. Baird | 0% 0/2 | 10 months ago | $252 179.81% upside | $199 | StreetInsider | Previous targets (1) |
David Rescott Robert W. Baird | 0% 0/2 | 11 months ago | $240 166.48% upside | $210.46 | StreetInsider | Previous targets (1) |
Michael Sarcone Jefferies | 0% 0/1 | about 1 year ago | $230 155.38% upside | $129.79 | StreetInsider | Previous targets (0) |
Richard Newitter Truist Financial | 50% 1/2 | about 1 year ago | $217 140.95% upside | $138.58 | TheFly | Previous targets (1) |
Kallum Titchmarsh Morgan Stanley | 50% 1/2 | about 1 year ago | $210 133.17% upside | $138.89 | TheFly | Previous targets (1) |
Adam Maeder Piper Sandler | 33.33% 1/3 | about 1 year ago | $255 183.14% upside | $139.4 | StreetInsider | Previous targets (2) |
Jonathan Block Stifel Nicolaus | 0% 0/1 | about 1 year ago | $170 88.76% upside | $162.46 | TheFly | Previous targets (0) |
Paige Meyer CFRA | 0% 0/1 | about 1 year ago | $175 94.31% upside | $166.32 | StreetInsider | Previous targets (0) |
Shagun Singh RBC Capital | 0% 0/1 | over 1 year ago | $285 216.45% upside | $241.15 | StreetInsider | Previous targets (0) |
Kallum Titchmarsh Morgan Stanley | 50% 1/2 | over 1 year ago | $250 177.59% upside | $204.45 | StreetInsider | Previous targets (1) |
Unknown J.P. Morgan | N/A | over 2 years ago | $300 233.11% upside | $249.58 | Benzinga | N/A |
Unknown Truist Financial | N/A | over 2 years ago | $308 241.99% upside | $248.81 | Benzinga | N/A |
Unknown Piper Sandler | N/A | about 3 years ago | $285 216.45% upside | $216.83 | Benzinga | N/A |
Richard Newitter Truist Financial | 50% 1/2 | about 3 years ago | $250 177.59% upside | $186.39 | TheFly | Previous targets (1) |
Adam Maeder Piper Sandler | 33.33% 1/3 | over 3 years ago | $310 244.21% upside | $213.56 | TheFly | Previous targets (2) |
Travis Steed Bank of America Securities | 100% 1/1 | over 3 years ago | $270 199.80% upside | $238.8 | Pulse 2.0 | Previous targets (0) |
Kyle Bauser Colliers Securities | 100% 1/1 | over 4 years ago | $266 195.35% upside | $240.68 | TipRanks | Previous targets (0) |
Inspire Medical Systems Financial Estimates
Inspire Medical Systems Revenue Estimates
Inspire Medical Systems EBITDA Estimates
Inspire Medical Systems Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $233.39M N/A | $407.85M 74.74% | $624.79M 53.19% | Avg: $949.91M Low: $901.79M High: $973.97M avg. 52.03% | Avg: $1.13B Low: $1.10B High: $1.15B avg. 19.48% | Avg: $1.37B Low: $1.33B High: $1.39B avg. 21.06% | Avg: $1.61B Low: $1.56B High: $1.64B avg. 17.55% |
Net Income
% change YoY
| $-42.04M N/A | $-44.88M -6.75% | $-21.15M 52.86% | Avg: $27.94M Low: $5.86M High: $70.32M avg. 232.10% | Avg: $80.98M Low: $27.83M High: $155.59M avg. 189.80% | Avg: $104.55M Low: $100.36M High: $106.98M avg. 29.10% | Avg: $139.03M Low: $133.47M High: $142.28M avg. 32.98% |
EBITDA
% change YoY
| $-39.84M N/A | $-42.59M -6.89% | $-17.06M 59.94% | Avg: $-227.00M Low: $-232.75M High: $-215.50M avg. -1230.62% | Avg: $-271.23M Low: $-276.09M High: $-262.89M avg. -19.48% | Avg: $-328.36M Low: $-334.25M High: $-318.26M avg. -21.06% | Avg: $-386.00M Low: $-392.93M High: $-374.13M avg. -17.55% |
EPS
% change YoY
| -$1.54 N/A | -$1.6 -3.89% | -$0.72 55.00% | Avg: $0.86 Low: $0.2 High: $2.4 avg. 219.12% | Avg: $2.36 Low: $0.95 High: $5.31 avg. 174.69% | Avg: $3.57 Low: $3.43 High: $3.65 avg. 51.43% | Avg: $4.75 Low: $4.56 High: $4.86 avg. 32.98% |
Operating Expenses
% change YoY
| $239.96M N/A | $389.33M 62.24% | $568.49M 46.01% | Avg: $871.76M Low: $827.59M High: $893.83M avg. 53.34% | Avg: $1.04B Low: $1.00B High: $1.06B avg. 19.48% | Avg: $1.26B Low: $1.22B High: $1.28B avg. 21.06% | Avg: $1.48B Low: $1.43B High: $1.50B avg. 17.55% |
FAQ
What is Inspire Medical Systems stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 120.99% in 2025-2028.
We have gathered data from 13 analysts. Their low estimate is 5.86M, average is 27.94M and high is 70.32M.
What is Inspire Medical Systems stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 27.53% in 2025-2028.
We have gathered data from 14 analysts. Their low revenue estimate is $901.79M, average is $949.91M and high is $973.97M.
What is Inspire Medical Systems stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 119.56% in 2025-2028.
We have gathered data from 13 analysts. Their low earnings per share estimate is $0.2, average is $0.86 and high is $2.4.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Inspire Medical Systems stock. The most successful analyst is Adam Maeder whose win rate is 33.33%. He has correctly predicted 1/3 price targets.